1. Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry. (24th May 2019) Authors: Mazieres, J; Drilon, A; Lusque, A; Mhanna, L; Cortot, A B; Mezquita, L; Thai, A A; Mascaux, C; Couraud, S; Veillon, R; Van den Heuvel, M; Neal, J; Peled, N; Früh, M; Ng, T L; Gounant, V; Popat, S; Diebold, J; Sabari, J; Zhu, V W Journal: Annals of oncology Issue: Volume 30:Number 8(2019) Page Start: 1321 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Machine learning-based predictors for immune checkpoint inhibitor therapy of non-small-cell lung cancer. (11th February 2019) Authors: Wiesweg, M; Mairinger, F; Reis, H; Goetz, M; Walter, R F H; Hager, T; Metzenmacher, M; Eberhardt, W E E; McCutcheon, A; Köster, J; Stuschke, M; Aigner, C; Darwiche, K; Schmid, K W; Rahmann, S; Schuler, M Journal: Annals of oncology Issue: Volume 30:Number 4(2019) Page Start: 655 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗